Medtronic Plc
NYSE: MDT
$88.24
-$1.88 (-2.1%)
Real Time Data Delayed 15 Min.
MDT Articles
These are ten of the analyst calls we are focusing on this morning: Central Garden (NASDAQ: CENT) raised to Buy at Piper Jaffray. China Sunergy (NASDAQ: CSUN) raised to Hold at Jefferies. El Paso...
Published:
Salient Surgical Technologies, Inc. has filed to come public via an initial public offering and has applied to trade on the NASDAQ under the ticker "SLNT." The company lists that it will sell up to...
Published:
These are some of the top analyst calls this morning: Alcoa (NYSE: AA) cut to Market Perform at FBR. Dr. Reddy’s (NYSE: RDY) cut to Hold at Citigroup. Freeport-McMoRan (NYSE: FCX) cut to Market...
Published:
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery...
Published:
Below is the short interest for major companies traded on the NYSE and changes from October 15, 2007 to the most current date, October 31, 2007. Company ...
Published:
Medtronic (MDT) is warning doctors and patients to look at the company’s latest "defibrillator models because it was prone to a defect that has caused malfunctions in hundreds of patients and may...
Published:
According to Reuters, Citigroup (C) and other large banksare planning to create a roughly $80 billion fund to buy ailing mortgage securities and other assets. Reuters writes that Medtronic (MDT) is...
Published:
Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns about whether the product has long-term risks or whether it is more effective...
Published:
According to Reuters, several retailers cut holiday forecasts and the economy slows. Reuters writes that Chrysler has reached an accord with the UAW. Reuters reports that Boeing (BA) has delayed...
Published:
Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It is a perverse selection because Boston Scientific (BSX) and Johnson & Johnson...
Published:
Medtronic (NYSE:MDT) posts earnings after the close on Tuesday, August 21, and First Call estimates are $0.62 EPS on $3.17 Billion in revenues. The following quarter is looking like estimates are...
Published:
(ADTN) Adtran $0.28 EPS versus $0.28 estimate.(AIZ) Assurant CEO and CFO received SEC WELLS NOTICE.(ASD) American Standard noted as a positive ahead of split-up by Cramer on MAD MONEY.(CVO) Cenveo is...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published:
Medtronic (MDT-NYSE) posted quarterly results with revenues up 75 to $3.28 Billion, helped on currency by $71 million. Net earnings were 4812 million, or $0.70 EPS but $0.66 adjusting for charges...
Published: